For citations:

Zhuravleva M.V., Tereshchenko S.N., Zhirov I.V., Nedogoda S.V., Gagarina Yu.V., Shabalina E.A. Сost-effectiveness of preventing cardiovascular death and achieving the target indicator "Reduction of the cardiovascular mortality of the population" of the State Program "Health Development" when using valsartan+sacubitril, dapagliflozin and empagliflozin in patients with heart failure with reduced ejection fraction. Russian Journal of Cardiology. 2023;28(3):5386. (In Russ.) https://doi.org/10.15829/1560-4071-2023-5386